Filters: Author is Bruce, R Douglas [Clear All Filters]
"Editorial comment: why treat three conditions when it is one patient?" The AIDS reader 13, no. 8 (2003): 378-9.
"Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice." Journal of acquired immune deficiency syndromes (1999) 41, no. 5 (2006): 563-72. Abstract
"Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S48-53. Abstract
"Models for integrating buprenorphine therapy into the primary HIV care setting." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42, no. 5 (2006): 716-21. Abstract
"Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir." AIDS (London, England) 20, no. 5 (2006): 783-4.
"Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence." The American journal of drug and alcohol abuse 33, no. 5 (2007): 643-54. Abstract
"HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications." The International journal on drug policy 18, no. 4 (2007): 326-8. Abstract
"Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services." The International journal on drug policy 18, no. 4 (2007): 306-12. Abstract
"Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 46, no. 5 (2007): 555-63. Abstract
"Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence." Journal of substance abuse treatment 32, no. 4 (2007): 399-409. Abstract
"Clinical care of the HIV-infected drug user." Infectious disease clinics of North America 21, no. 1 (2007): 149-79, ix. Abstract
"Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45, no. 6 (2007): 770-8. Abstract
"Case series of buprenorphine injectors in Kuala Lumpur, Malaysia." The American journal of drug and alcohol abuse 34, no. 4 (2008): 511-7. Abstract
"Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy." AIDS and behavior 12, no. 2 (2008): 284-93. Abstract
"Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening." The American journal of drug and alcohol abuse 35, no. 6 (2009): 439-44. Abstract
"Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market." The American journal of drug and alcohol abuse 35, no. 2 (2009): 68-72. Abstract
"Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone." Drug and alcohol dependence 105, no. 3 (2009): 234-9. Abstract
"Medication assisted treatment in the treatment of drug abuse and dependence in HIV/AIDS infected drug users." Current HIV research 7, no. 4 (2009): 354-64. Abstract
"Diagnosis of acute HIV infection in Connecticut." Connecticut medicine 73, no. 6 (2009): 325-31. Abstract
"Medical interventions for addictions in the primary care setting." Topics in HIV medicine : a publication of the International AIDS Society, USA 18, no. 1 (2010): 8-12. Abstract
"Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users." AIDS (London, England) 24, no. 3 (2010): 331-40. Abstract
"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings." The International journal on drug policy 21, no. 2 (2010): 122-4. Abstract
"Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone." The American journal of drug and alcohol abuse 37, no. 4 (2011): 224-8. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence." Journal of substance abuse treatment (2012). Abstract
"Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication." The American journal of drug and alcohol abuse 38, no. 3 (2012): 206-12. Abstract
"Identifying programmatic gaps: inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania." PloS one 8, no. 6 (2013): e67062. Abstract
"The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment." Journal of acquired immune deficiency syndromes (1999) (2013). Abstract
"An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2013). Abstract
"Is it time for treatment as prevention among people who inject drugs?" Journal of acquired immune deficiency syndromes (1999) 63, no. 5 (2013): 545-7.
"Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy 57, no. 12 (2013): 6154-7. Abstract
"Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program." The American journal of drug and alcohol abuse 39, no. 4 (2013): 247-51. Abstract
"Reducing the health consequences of opioid addiction in primary care." The American journal of medicine 126, no. 7 (2013): 565-71. Abstract
"A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice." Expert review of clinical pharmacology 6, no. 3 (2013): 249-69. Abstract
"The marketing of methadone: how an effective medication became unpopular." The International journal on drug policy 24, no. 6 (2013): e89-90.
"Latent tuberculosis infection: screening and treatment in an urban setting." Journal of community health 38, no. 5 (2013): 941-50. Abstract
"An investigation of the interactions between methadone and elvitegravir/cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy (2013). Abstract
"Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment." The International journal on drug policy 25, no. 1 (2014): 22-5. Abstract
"Latent Tuberculosis Infection Screening in Foreign-Born Populations: A Successful Mobile Clinic Outreach Model." American journal of public health (2014): e1-e8. Abstract
"Methadone Treatment for HIV Prevention-Feasibility, Retention and Predictors of Attrition in Dar es Salaam, Tanzania: A Retrospective Cohort Study." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2014). Abstract
"Reaching the Unreached: Treatment as Prevention as a Workable Strategy to Mitigate HIV and Its Consequences in High-Risk Groups." Current HIV/AIDS reports (2014). Abstract
"Epidemiology of Drug Use and HIV-Related Risk Behaviors among People Who Inject Drugs in Mwanza, Tanzania." PloS one 10, no. 12 (2015): e0145578. Abstract
"Epidemiology of Drug Use and HIV-Related Risk Behaviors among People Who Inject Drugs in Mwanza, Tanzania." PloS one 10, no. 12 (2015): e0145578. Abstract
"Drug interactions between buprenorphine, methadone and hepatitis C therapeutics." Expert opinion on drug metabolism & toxicology (2016). Abstract
